Neogenomics Inc
NEO· Nasdaq
NEONeogenomics Inc
Filed May 13, 2013 · 10-Q · 43 days after period end · 0001193125-13-214728
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Net Income | $3.00K | $603.00K | -$893.00K |
| EPS Diluted | $0.00 | $0.01 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 13, 2013 · 43 d after period end
